Medicamen Biotech Ltd. — Director's Dealing 2021

Dec 14, 2021

MEDICAMEN Biotech Limited

Regd. & Corp. Office: 1506, Chiranjiv Tower, 43, Nehru Place, New Delhi - 110019 (INDIA)

Tel.: 011 - 47589500-51 (50 Lines), E-mail: info@medicamen.com Web: www.medicamen.com CIN No.: L74899DL1993PLC056594

Dated: 14.12.2021

To. BSE Limited Floor 25, P J Towers Dalal Street Mumbai-400001

National Stock Exchange of India Ltd Exchange Plaza, C-1, Block G, Bandra Kurla Complex, Bandra (E) Mumbai - 400 051

Scrip Code: 531146

Subject: Intimation as per Regulation 7(2)(b) of the SEBI (Prohibition of Insider Trading) Regulations, 2015

Dear Sir/Madam.

Please find attached disclosure dated December 13, 2021 in Form-C pursuant to Regulation 7(2)(a) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 with respect to intimation received from Growel Remedies Limited for sale of 20,500 Equity Shares from the open market.

We request you to treat this intimation as compliance with Regulation $7(2)$ (b) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 and take the same on record.

Biota For Medicamen Biotech Limited 3 $\omega$ Parul Choudharv

Company Secretary ACS: 44157

Encl: A/a

Dated: 13.12.2021

To, The Compliance Officer Medicamen Biotech Limited 1506, Chiranjiv Tower, 43, Nehru Place, New Delhi, 110019

Subject: Submission of disclosure under Regulation $7(2)(a)$ read with regulation $6(2)$ of SEBI (Prohibition of Insider Trading) Regulations, 2015

Dear Sir/Madam,

With reference to the above captioned subject, we would like to apprise you that Growel Remedies Limited (Promoter of Medicamen Biotech Limited ("Target Company") has sold 20,500 Equity Shares of Rs. 10/- each through the open market.

In this connection please find enclosed the required disclosure.

You are requested to take the above information on your records and inform the exchange accordingly.

For Growel Remedies Limited

Rahul Bishnoi Director DIN: 00317960

Encl: A/a

FORM C SEBI (Prohibition of Insider Trading) Regulations, 2015 !Regulation 7 (2) read with Regulation 6(2) - Continual disclosure I

Name of the company: Medicamen Biotech Limited !SIN of the company: INE646B01010

Details of change in holding of Securities of Promoter, Member of the Promoter GroHp, Designated Person or Direetor of a listed company and immediate relatives of such persons and other such persons as mentioned in Regulation 6(2).

Name, PAN, CIN/DIN, & address with contact nos.	Category of Securities held Person prior to (Promoter/ acquisition/disposal member of the promoter group/desig			Securities aeqHired/Disposed				Securities held post acqHisition/disposal		Date of allotment advice/ acquisition of shares,/ disposal of shares specify		Date of to	Mode of intimation acquisition / disposal ( on company market/pub! ic I rights/ preferential
	nated person/ Director s/immediate relative to/others etc.)	Type of security (For eg. - Shares, Warrants, Convertible Debentures Rights entitlements etc.)	No. and% of ing	Type of security sharehold (For eg. - Shares, Warrant s, Converti ble Debentu res Rights entitlem ents etc.)etc.)	No.	Value (In Rs.)	Transact Type of ion Type (Purchase Shares, /sale ~· ·o· Re,•ocati le � ft!. � j:rlease �)	security (For eg.- Warrants, Convertib Debenture ln,•ocatio s Rights entitleme nt, etc.)	No. and% of shareholding	From	To		offer / off market/ Inter se transfer, ESOPs etc.)
'fame: Growel Remedies Limited formerly Grawe! Wellness Innovations Ltd.) PAN: AABCG3108P Address: 1506 , Chiranjiv fower,43, Nehru Place, New Delhi-I 10019 Contact No.: ft-919810739079	Promoter (group)	Equity shares 3,58,019	equity shares (2.93%)	Equity Shares	20,500 Equity Shares	Rs. 1,95,46,081 (Rupees One Crore Ninety Five Lakhs Forty Six Thousand and Eighty One only/-)	Sale	Equity Shares	3,37,519 equity shares (2.76%)	10.12.2021 13.12.2021	��� /	�	13.12.2021 On Market ---- �edio,_ '0 , " / . ' . -__' .-1 i c 1 I - �

Details of trading in derivatives of the company by Promoter, Employee or Director of a listed company and other such persons as mentioned in Regulation 6(2).
Trading in derivatives (Specify type of contract, Futures or Options etc)
			Buy	Sell
Type of contract	Contract specifications	Notional Value	Number of units (contracts * lot) size)	Notional Value	Number of units (contracts * lot size)
NA	NA	NA	NA	NA	NA	NA

Note: In case of Options, notional value shall be calculated based on Premium plus strike price of options.

Yours faithfully

For Growel Remedies Ltd

Rahul Bishnoi Director DIN: 00317960

Date: 13.12.2021 Place: New Delhi

******